Division of Microbiome & Cancer, DKFZ, Heidelberg, Germany.
Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
PLoS Biol. 2023 Mar 17;21(3):e3002053. doi: 10.1371/journal.pbio.3002053. eCollection 2023 Mar.
Human microbiome research is evolving from describing associations to understanding the impact of bioactive strains on humans. Despite challenges, progress is being made to apply data-driven microbiome diagnostics and interventions, potentially leading to precision medicine breakthroughs in the next decade.
人类微生物组研究正从描述相关性发展到理解生物活性菌株对人类的影响。尽管存在挑战,但在应用基于数据的微生物组诊断和干预方面正在取得进展,这可能在未来十年带来精准医学的突破。